Sysmex Inostics
Celina Tretter is a Scientist & Team Lead at Sysmex Inostics, with previous experience as a PHD Student at DKFZ German Cancer Research Center and as a Master-Student at the University of Oxford. Celina also gained experience as an intern and bachelor student at Indivumed Group, as a student assistant at Universitätsklinikum Hamburg Eppendorf, and in a student research project at the Institute of Neuroimmunology und Multiple Sclerosis. Celina holds a Master of Science in Integrated Immunology from the University of Oxford, a Bachelor of Science in Molecular Life Sciences from the University of Hamburg, and is currently pursuing a Doctor of Philosophy in Translational Tumour Immunology at the Technical University of Munich.
This person is not in any offices
Sysmex Inostics
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.